Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Mokrasch, I. Stevenson (1959)
THE METABOLISM OF MESCALINE WITH A NOTE ON CORRELATIONS BETWEEN METABOLISM AND PSYCHOLOGICAL EFFECTSThe Journal of Nervous and Mental Disease, 129
(1952)
Schizophrenia: a new approach.The Journal of mental science, 105
C. Smith (1958)
A new adjunct to the treatment of alcoholism: the hallucinogenic drugs.Quarterly journal of studies on alcohol, 19 3
C. Savage (1957)
THE RESOLUTION AND SUBSEQUENT REMOBILIZATION OF RESISTANCE BY LSD IN PSYCHOTHERAPYThe Journal of Nervous and Mental Disease, 125
H. Sullivan (1929)
RESEARCH IN SCHIZOPHRENIAAmerican Journal of Psychiatry, 86
A. Hoffer, H. Osmond, J. Smythies (1954)
Schizophrenia; a new approach. II. Result of a year's research.The Journal of mental science, 100 418
H. Denber, M. Rinkel (1957)
PSYCHODYNAMIC AND THERAPEUTIC ASPECTS OF MESCALINE AND LYSERGIC ACID DIETHYLAMIDE ROUND TABLEThe Journal of Nervous and Mental Disease, 125
I. Stevenson, A. Sanchez (1957)
The antidotal action of sodium succinate in the mescaline psychosis.The American journal of psychiatry, 114 4
J. Harley-Mason, A. Laird, J. Smythies (1958)
I) The Metabolism of Mescalin in the Human (II) Delayed Clinical Reactions to MescalinStereotactic and Functional Neurosurgery, 18
A. Martin (1957)
L.S.D. (Lysergic Acid Diethylamide) Treatment of Chronic Psychoneurotic Patients Under Day-Hospital ConditionsInternational Journal of Social Psychiatry, 3
(1954)
HALLUCINOGENIC DRUGSMedical Journal of Australia, 1
(1958)
Co~E~: Psychotherapy with LSD
I. Stevenson, L. Mokrasch (1958)
A further note on the mechanism of the antidotal action of sodium succinate in the mescaline psychosis.The American journal of psychiatry, 114 11
H. Cooper (1955)
Hallucinogenic drugs.Lancet, 268 6873
(1936)
Contribution a la psychopathologic de l'intoxication par la Mescaline. Le probleme d'une schizophrenic exp6rimentale
B. Eisner, S. Cohen (1958)
PSYCHOTHERAPY WITH LYSERGIC ACID DIETHYLAMIDEThe Journal of Nervous and Mental Disease, 127
R. Sandison, J. Whitelaw (1957)
Further studies in the therapeutic value of lysergic acid diethylamide in mental illness.The Journal of mental science, 103 431
213 1 1 3 3 Ian Stevenson Thomas W. Richards Department of Neurology and Psychiatry, School of Medicine University of Virginia Charlottesville Department of Psychiatry and Neurology Louisiana State University, School of Medicine New Orleans Summary 1. Two cases of prolonged reactions to mescaline (400 mg. orally, one lasting four days, one lasting eleven days are reported. 2. The two subjects showing these prolonged reactions had reactions during the periods of maximal intoxication which were more severe than those of most other subjects in a series of 47 experiments on 25 subjects. Their reactions, however, were not more severe than those of some other subjects who did not have prolonged reactions. 3. In both subjects the reactions resembled mild schizophrenic reactions. One subject had a life-long pattern of withdrawal into fantasies during stress. He took mescaline at a time of stress in his life. The mescaline seems to have reinforced his pattern of withdrawal making it temporarily of psychotic proportions.
Psychopharmacology – Springer Journals
Published: May 1, 1960
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.